Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections
Preprint
- 17 March 2020
- preprint
- Published by Cold Spring Harbor Laboratory
Abstract
The World Health Organization has recently declared the ongoing outbreak of COVID-19, which is caused by a novel coronavirus SARS-CoV-2, as pandemic. There is currently a lack of knowledge in the antibody response elicited from SARS-CoV-2 infection. One major immunological question is concerning the antigenic differences between SARS-CoV-2 and SARS-CoV. We address this question by using plasma from patients infected by SARS-CoV-2 or SARS-CoV, and plasma obtained from infected or immunized mice. Our results show that while cross-reactivity in antibody binding to the spike protein is common, cross-neutralization of the live viruses is rare, indicating the presence of non-neutralizing antibody response to conserved epitopes in the spike. Whether these non-neutralizing antibody responses will lead to antibody-dependent disease enhancement needs to be addressed in the future. Overall, this study not only addresses a fundamental question regarding the antigenicity differences between SARS-CoV-2 and SARS-CoV, but also has important implications in vaccine development.Keywords
Other Versions
- Published version: Version Cell Reports, 31, preprints
This publication has 35 references indexed in Scilit:
- Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteinsBiochemical and Biophysical Research Communications, 2014
- Highly Conserved Protective Epitopes on Influenza B VirusesScience, 2012
- Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS VirusPLOS ONE, 2012
- A Highly Conserved Neutralizing Epitope on Group 2 Influenza A VirusesScience, 2011
- Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape MutantsPLoS Medicine, 2006
- Recombinant Modified Vaccinia Virus Ankara Expressing the Spike Glycoprotein of Severe Acute Respiratory Syndrome Coronavirus Induces Protective Neutralizing Antibodies Primarily Targeting the Receptor Binding RegionJournal of Virology, 2005
- A DNA vaccine induces SARS coronavirus neutralization and protective immunity in miceNature, 2004
- Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirusNature, 2003
- Synergistic Interactions of Anti-NS1 Monoclonal Antibodies Protect Passively Immunized Mice from Lethal Challenge with Dengue 2 VirusJournal of General Virology, 1988
- Antibody-mediated enhancement of disease in feline infectious peritonitis: Comparisons with dengue hemorrhagic feverComparative Immunology, Microbiology and Infectious Diseases, 1981